An 8-Week Self-Administered At-Home Behavioral Skills-Based Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial Conducted During COVID-19

物理疗法 医学 慢性疼痛 心情 随机对照试验 剧痛 安慰剂 物理医学与康复 临床心理学 外科 病理 替代医学
作者
Laura Martínez García,Brandon Birckhead,Parthasarathy Krishnamurthy,Josh Sackman,Ian Mackey,Robert G. Louis,Vafi Salmasi,Todd Maddox,Beth D. Darnall
出处
期刊:Journal of Medical Internet Research [JMIR Publications]
卷期号:23 (2): e26292-e26292 被引量:82
标识
DOI:10.2196/26292
摘要

Background Chronic low back pain is the most prevalent chronic pain condition worldwide and access to behavioral pain treatment is limited. Virtual reality (VR) is an immersive technology that may provide effective behavioral therapeutics for chronic pain. Objective We aimed to conduct a double-blind, parallel-arm, single-cohort, remote, randomized placebo-controlled trial for a self-administered behavioral skills-based VR program in community-based individuals with self-reported chronic low back pain during the COVID-19 pandemic. Methods A national online convenience sample of individuals with self-reported nonmalignant low back pain with duration of 6 months or more and with average pain intensity of 4 or more/10 was enrolled and randomized 1:1 to 1 of 2 daily (56-day) VR programs: (1) EaseVRx (immersive pain relief skills VR program); or (2) Sham VR (2D nature content delivered in a VR headset). Objective device use data and self-reported data were collected. The primary outcomes were the between-group effect of EaseVRx versus Sham VR across time points, and the between–within interaction effect representing the change in average pain intensity and pain-related interference with activity, stress, mood, and sleep over time (baseline to end-of-treatment at day 56). Secondary outcomes were global impression of change and change in physical function, sleep disturbance, pain self-efficacy, pain catastrophizing, pain acceptance, pain medication use, and user satisfaction. Analytic methods included intention-to-treat and a mixed-model framework. Results The study sample was 179 adults (female: 76.5%, 137/179; Caucasian: 90.5%, 162/179; at least some college education: 91.1%, 163/179; mean age: 51.5 years [SD 13.1]; average pain intensity: 5/10 [SD 1.2]; back pain duration ≥5 years: 67%, 120/179). No group differences were found for any baseline variable or treatment engagement. User satisfaction ratings were higher for EaseVRx versus Sham VR (P<.001). For the between-groups factor, EaseVRx was superior to Sham VR for all primary outcomes (highest P value=.009), and between-groups Cohen d effect sizes ranged from 0.40 to 0.49, indicating superiority was moderately clinically meaningful. For EaseVRx, large pre–post effect sizes ranged from 1.17 to 1.3 and met moderate to substantial clinical importance for reduced pain intensity and pain-related interference with activity, mood, and stress. Between-group comparisons for Physical Function and Sleep Disturbance showed superiority for the EaseVRx group versus the Sham VR group (P=.022 and .013, respectively). Pain catastrophizing, pain self-efficacy, pain acceptance, prescription opioid use (morphine milligram equivalent) did not reach statistical significance for either group. Use of over-the-counter analgesic use was reduced for EaseVRx (P<.01) but not for Sham VR. Conclusions EaseVRx had high user satisfaction and superior and clinically meaningful symptom reduction for average pain intensity and pain-related interference with activity, mood, and stress compared to sham VR. Additional research is needed to determine durability of treatment effects and to characterize mechanisms of treatment effects. Home-based VR may expand access to effective and on-demand nonpharmacologic treatment for chronic low back pain. Trial Registration ClinicalTrials.gov NCT04415177; https://clinicaltrials.gov/ct2/show/NCT04415177 International Registered Report Identifier (IRRID) RR2-10.2196/25291

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
6260完成签到,获得积分10
刚刚
pcr163应助linhanwenzhou采纳,获得50
1秒前
1秒前
酷酷元风完成签到,获得积分10
2秒前
3秒前
天才幸运鱼完成签到,获得积分10
3秒前
4秒前
4秒前
粥游天下完成签到,获得积分10
5秒前
jcc完成签到,获得积分10
5秒前
哈哈哈哈完成签到,获得积分10
5秒前
lighthouse完成签到,获得积分10
6秒前
平凡中的限量版完成签到,获得积分10
6秒前
大伟完成签到,获得积分10
6秒前
long关注了科研通微信公众号
7秒前
懵懂的毛豆完成签到,获得积分10
7秒前
zzcherished发布了新的文献求助10
7秒前
zyq发布了新的文献求助10
7秒前
我是老大应助哦哦哦采纳,获得10
8秒前
YHY完成签到,获得积分10
8秒前
8秒前
天天呼的海角完成签到,获得积分10
11秒前
量子星尘发布了新的文献求助10
14秒前
14秒前
14秒前
jiangcai完成签到,获得积分10
15秒前
Cherry完成签到,获得积分10
17秒前
正能量的可可可完成签到,获得积分10
17秒前
tuo zhang发布了新的文献求助10
20秒前
草莓养乐多完成签到 ,获得积分10
20秒前
糊涂完成签到,获得积分10
20秒前
哦哦哦发布了新的文献求助10
20秒前
in完成签到 ,获得积分10
21秒前
pilot完成签到,获得积分10
23秒前
劣根完成签到,获得积分10
24秒前
Liang发布了新的文献求助20
24秒前
26秒前
27秒前
曾小莹完成签到,获得积分10
27秒前
苏信怜完成签到,获得积分10
28秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029